Sg3 Management, LLC Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $316,400 - $458,328	11,300 New	11,300 $458,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $1.46 Million - $2.12 Million	-25,000 Reduced 45.45%	30,000 $1.87 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $3.37 Million - $4.98 Million	55,000 New	55,000 $3.65 Million
Q1 2019 May 14, 2019	SELL	$12.05 - $20.18 $24,100 - $40,360	-2,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$10.74 - $19.7 $21,480 - $39,400	2,000 New	2,000 $25,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.